
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review
Page Axley, Zunirah Ahmed, Sujan Ravi, et al.
Journal of Clinical and Translational Hepatology (2017) Vol. 6, Iss. 2, pp. 1-6
Open Access | Times Cited: 225
Page Axley, Zunirah Ahmed, Sujan Ravi, et al.
Journal of Clinical and Translational Hepatology (2017) Vol. 6, Iss. 2, pp. 1-6
Open Access | Times Cited: 225
Showing 1-25 of 225 citing articles:
RETRACTED ARTICLE: Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7
Haiyang Zhang, Ting Deng, Shaohua Ge, et al.
Oncogene (2018) Vol. 38, Iss. 15, pp. 2844-2859
Open Access | Times Cited: 285
Haiyang Zhang, Ting Deng, Shaohua Ge, et al.
Oncogene (2018) Vol. 38, Iss. 15, pp. 2844-2859
Open Access | Times Cited: 285
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 433-452
Open Access | Times Cited: 45
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 433-452
Open Access | Times Cited: 45
Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis
Jie Wang, Kaijie Qiu, Shengfan Zhou, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 3
Jie Wang, Kaijie Qiu, Shengfan Zhou, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 3
Complex roles of the old drug aspirin in cancer chemoprevention and therapy
Hui Hua, Hongying Zhang, Qingbin Kong, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 114-145
Open Access | Times Cited: 102
Hui Hua, Hongying Zhang, Qingbin Kong, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 114-145
Open Access | Times Cited: 102
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3057-3057
Open Access | Times Cited: 79
Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3057-3057
Open Access | Times Cited: 79
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review
Malik Sallam, Roaa Khalil
Microorganisms (2024) Vol. 12, Iss. 6, pp. 1035-1035
Open Access | Times Cited: 11
Malik Sallam, Roaa Khalil
Microorganisms (2024) Vol. 12, Iss. 6, pp. 1035-1035
Open Access | Times Cited: 11
A Landscape of Cancer Initiation and Cancer Stem Cells
Masaharu Seno
Cancers (2025) Vol. 17, Iss. 2, pp. 203-203
Open Access | Times Cited: 1
Masaharu Seno
Cancers (2025) Vol. 17, Iss. 2, pp. 203-203
Open Access | Times Cited: 1
Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
Luca Rinaldi, Riccardo Nevola, Gianluigi Franci, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1351-1351
Open Access | Times Cited: 69
Luca Rinaldi, Riccardo Nevola, Gianluigi Franci, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1351-1351
Open Access | Times Cited: 69
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, et al.
Hepatology Communications (2021) Vol. 6, Iss. 4, pp. 679-691
Open Access | Times Cited: 48
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, et al.
Hepatology Communications (2021) Vol. 6, Iss. 4, pp. 679-691
Open Access | Times Cited: 48
Road to elimination of HCV: Clinical challenges in HCV management
C. Nelson Hayes, Michio Imamura, Junko Tanaka, et al.
Liver International (2021) Vol. 42, Iss. 9, pp. 1935-1944
Closed Access | Times Cited: 44
C. Nelson Hayes, Michio Imamura, Junko Tanaka, et al.
Liver International (2021) Vol. 42, Iss. 9, pp. 1935-1944
Closed Access | Times Cited: 44
Interventional nanotheranostics in hepatocellular carcinoma
Vivek P. Chavda, Pankti C. Balar, Srushti B. Patel
Nanotheranostics (2023) Vol. 7, Iss. 2, pp. 128-141
Open Access | Times Cited: 18
Vivek P. Chavda, Pankti C. Balar, Srushti B. Patel
Nanotheranostics (2023) Vol. 7, Iss. 2, pp. 128-141
Open Access | Times Cited: 18
Learning from the nexus of autoimmunity and cancer
Davide Mangani, Dandan Yang, Ana C. Anderson
Immunity (2023) Vol. 56, Iss. 2, pp. 256-271
Open Access | Times Cited: 18
Davide Mangani, Dandan Yang, Ana C. Anderson
Immunity (2023) Vol. 56, Iss. 2, pp. 256-271
Open Access | Times Cited: 18
Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation
Ze Xiang, Jian Wu, Jiarui Li, et al.
Engineering (2023) Vol. 29, pp. 59-72
Open Access | Times Cited: 18
Ze Xiang, Jian Wu, Jiarui Li, et al.
Engineering (2023) Vol. 29, pp. 59-72
Open Access | Times Cited: 18
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis
Maria Guarino, Luca Viganò, Francesca Romana Ponziani, et al.
Digestive and Liver Disease (2018) Vol. 50, Iss. 11, pp. 1105-1114
Closed Access | Times Cited: 55
Maria Guarino, Luca Viganò, Francesca Romana Ponziani, et al.
Digestive and Liver Disease (2018) Vol. 50, Iss. 11, pp. 1105-1114
Closed Access | Times Cited: 55
MiR-155 and MiR-665 role as potential non-invasive biomarkers for hepatocellular carcinoma in Egyptian patients with chronic hepatitis C virus infection
Amal Ahmed Mohamed, Abdellah A. Omar, Rehab El-Awady, et al.
Journal of Translational Internal Medicine (2020) Vol. 8, Iss. 1, pp. 32-40
Open Access | Times Cited: 49
Amal Ahmed Mohamed, Abdellah A. Omar, Rehab El-Awady, et al.
Journal of Translational Internal Medicine (2020) Vol. 8, Iss. 1, pp. 32-40
Open Access | Times Cited: 49
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma
Yinan Zheng, Ryan A. Hlady, Brian T. Joyce, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Yinan Zheng, Ryan A. Hlady, Brian T. Joyce, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe, Neale D. Ridgway
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2606-2606
Open Access | Times Cited: 40
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe, Neale D. Ridgway
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2606-2606
Open Access | Times Cited: 40
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
Timothy J. Brown, Ronac Mamtani, Phyllis A. Gimotty, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 6, pp. 2345-2354
Open Access | Times Cited: 14
Timothy J. Brown, Ronac Mamtani, Phyllis A. Gimotty, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 6, pp. 2345-2354
Open Access | Times Cited: 14
Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
Jung Eun Park, Vy H. Nguyen, Pei‐Chien Tsai, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 6, pp. 742-751
Closed Access | Times Cited: 6
Jung Eun Park, Vy H. Nguyen, Pei‐Chien Tsai, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 6, pp. 742-751
Closed Access | Times Cited: 6
Structure-based virtual screening of unbiased and RNA-focused libraries to identify new ligands for the HCV IRES model system
Elisabeth Kallert, Laura Almena Rodriguez, Jan-Åke Husmann, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1527-1538
Open Access | Times Cited: 5
Elisabeth Kallert, Laura Almena Rodriguez, Jan-Åke Husmann, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1527-1538
Open Access | Times Cited: 5
Surface enhanced Raman spectroscopy of RNA samples extracted from blood of hepatitis C patients for quantification of viral loads
Saira Nasir, Muhammad Irfan Majeed, Haq Nawaz, et al.
Photodiagnosis and Photodynamic Therapy (2020) Vol. 33, pp. 102152-102152
Closed Access | Times Cited: 36
Saira Nasir, Muhammad Irfan Majeed, Haq Nawaz, et al.
Photodiagnosis and Photodynamic Therapy (2020) Vol. 33, pp. 102152-102152
Closed Access | Times Cited: 36
Deubiquitination and Activation of the NLRP3 Inflammasome by UCHL5 in HCV-Infected Cells
Akshaya Ramachandran, Binod Kumar, Gulam Waris, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Akshaya Ramachandran, Binod Kumar, Gulam Waris, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Regions of hepatitis C virus E2 required for membrane association
Ashish Kumar, Tiana C. Rohe, Elizabeth J. Elrod, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Ashish Kumar, Tiana C. Rohe, Elizabeth J. Elrod, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
The Role of Non-Coding RNAs in Liver Disease, Injury, and Regeneration
Melissa M. Rowe, Klaus H. Kaestner
Cells (2023) Vol. 12, Iss. 3, pp. 359-359
Open Access | Times Cited: 11
Melissa M. Rowe, Klaus H. Kaestner
Cells (2023) Vol. 12, Iss. 3, pp. 359-359
Open Access | Times Cited: 11